Finnegan is a sponsor of the 30th annual BioExecutive Forum meeting. Finnegan partner Gerson Panitch will present “Can IP be Protected in China?” The program will take place at the Tel Aviv Stock Exchange (TASE) in Tel Aviv, Israel. For more information, or to register, please see the BioExecutive Forum’s website.
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.